Beijing Foyou Pharma CO.,LTD (SHA:601089)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Offsets between Segments	-2.83M	-	-			-	-
Medical Instruments	201.97M	-	-			186.41M	197.07M
Medical Instruments Growth	-	-	-			-5.41%	-
Medicine	3.31B	-	-			2.32B	2.21B
Medicine Growth	-	-	-			5.22%	-
Others	-	-	-			23.54M	17.67M
Others Growth	-	-	-			33.20%	-
Total	3.50B	-	-			2.53B	2.42B
Total Growth	-	-	-			4.56%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
East China	1.38B	-	-			-	-
North China	532.67M	-	-			-	-
Southwest	452.01M	-	-			-	-
Central China	367.80M	-	-			-	-
South China	328.40M	-	-			-	-
Northeast	212.65M	-	-			-	-
Northwest	124.72M	-	-			-	-
Foreign	47.86M	-	-			-	-
Other China	295.84K	-	-			-	-
China	-	-	-			2.50B	2.39B
China Growth	-	-	-			4.77%	-
Nigeria	-	-	-			16.71M	15.31M
Nigeria Growth	-	-	-			9.13%	-
Myanmar	-	-	-			6.26M	8.45M
Myanmar Growth	-	-	-			-25.84%	-
U.S.	-	-	-			2.87M	6.30M
U.S. Growth	-	-	-			-54.48%	-
Other	-	-	-			3.58M	2.97M
Other Growth	-	-	-			20.73%	-
Total	3.44B	-	-			2.53B	2.42B
Total Growth	-	-	-			4.56%	-

Source: S&P Global Market Intelligence.